MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Gold-Standard Tetrazolium Salt for Cell Viability Assays

Executive Summary: MTT (CAS 298-93-1) is a cationic tetrazolium salt utilized globally for colorimetric quantification of cell viability and metabolic activity in vitro. Its reduction to purple formazan by mitochondrial and extramitochondrial NADH-dependent oxidoreductases provides a direct, quantitative signal of cellular health (see Hong Ye et al., 2023). APExBIO's MTT (SKU B7777) offers ≥98% purity, supporting reproducibility and sensitivity across diverse cell models. MTT is soluble at ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, and ≥2.5 mg/mL in water (ultrasound-assisted), with optimal storage at -20°C. The MTT assay is widely validated in cancer research, apoptosis measurement, and metabolic activity assays (see APExBIO product page).

Biological Rationale

Cell viability and proliferation are fundamental metrics in biomedical research, especially in oncology, regenerative medicine, and pharmacology. The MTT assay, based on the reduction of MTT by living cells, enables quantification of metabolic activity, which correlates with cell viability. MTT is membrane-permeable and cationic, facilitating efficient uptake by intact cells without the need for additional mediators, in contrast to anionic second-generation tetrazolium compounds (Cellron 2023). The assay is widely adopted for evaluating cytotoxicity, drug screening, apoptosis, and cellular responses to various stimuli. In cancer research, MTT is critical for assessing proliferation and apoptosis in cell lines such as A549 lung cancer cells (Hong Ye et al., 2023).

Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

MTT acts as a substrate for cellular oxidoreductase enzymes, primarily those associated with NADH or NADPH. Upon entering viable cells, MTT is reduced by mitochondrial succinate dehydrogenase and other extra-mitochondrial reductases, forming insoluble purple formazan crystals. This reaction proceeds optimally in metabolically active, intact cells and is directly proportional to the number of viable cells present. The formazan is subsequently solubilized (commonly in DMSO or isopropanol) to enable spectrophotometric quantification at 570 nm (APExBIO product documentation). The selectivity of MTT reduction for metabolically active cells underpins its utility for cell viability, cytotoxicity, and proliferation assays (Annexin-V-PE 2023—this article provides additional mechanistic insights compared to the present focus on product standards and performance).

Evidence & Benchmarks

• MTT assay reliably quantifies reductions in cell viability, as demonstrated in A549 lung cancer cells co-cultured with immunologically activated HUC-MSCs, showing decreased proliferation and increased apoptosis (Hong Ye et al., 2023).
• MTT is reduced by both mitochondrial and extra-mitochondrial oxidoreductases, ensuring a robust signal even in cells with altered mitochondrial function (Edu-Flow-Cytometry 2023).
• MTT solubility: ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, ≥2.5 mg/mL in water (ultrasonic assistance), enabling flexible workflow integration (APExBIO).
• Formazan quantification at 570 nm offers high linearity with cell number in the range of 1,000–100,000 cells/well under standard conditions (Cellron 2023).
• In comparative studies, MTT demonstrates similar or superior sensitivity and reproducibility to alternative tetrazolium salts for in vitro cell proliferation assays (Annexin-V-PE 2023).

Applications, Limits & Misconceptions

MTT is extensively used for:

• Quantitative measurement of cell viability in cancer research, including assessment of drug cytotoxicity and apoptosis (Hong Ye et al., 2023).
• Screening of anticancer compounds and metabolic modifiers (APExBIO).
• Evaluating proliferation in regenerative medicine and stem cell research (Annexin-V-APC 2023—this article expands upon translational research applications, whereas the present article details validated workflow and limitations).
• Measuring metabolic activity in apoptosis and cellular stress studies.

Common Pitfalls or Misconceptions

• MTT does not distinguish between different cell death modalities (apoptosis vs. necrosis); it only indicates metabolic activity.
• Compounds with inherent reducing properties or interfering chromophores can produce false-positive or negative results.
• MTT is not suitable for non-adherent or suspension cells without careful optimization, as formazan crystals may not be fully recovered.
• Long-term MTT solution storage can lead to decomposition and reduced assay sensitivity; solutions should be prepared fresh or stored at -20°C for short periods (APExBIO).
• High cell densities can saturate the assay, compromising linearity of absorbance readout.

Workflow Integration & Parameters

For optimal results, MTT (SKU B7777) from APExBIO should be dissolved at concentrations ≥41.4 mg/mL in DMSO, or ≥18.63 mg/mL in ethanol, or ≥2.5 mg/mL in water (ultrasonicated). Standard protocols involve adding MTT to cell cultures (final concentration 0.5 mg/mL), incubating for 2–4 hours at 37°C, and solubilizing formazan with DMSO or isopropanol before reading absorbance at 570 nm (APExBIO protocol). For high-throughput screening, automation-compatible workflows are established (Annexin-V-PE 2023—this resource provides expanded troubleshooting and advanced protocol modifications).

MTT is compatible with multiwell plate formats (96-, 384-well). To maintain reproducibility, standardize cell seeding density, incubation time, and solubilization steps. APExBIO recommends using freshly prepared solutions and minimizing light exposure. Proper controls (media-only, cell-free wells) are required to account for background absorbance.

Conclusion & Outlook

MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) remains the reference standard for colorimetric cell viability and metabolic activity measurement in vitro, supported by decades of peer-reviewed evidence and robust product quality from APExBIO. While newer tetrazolium salts and fluorometric assays have emerged, MTT's simplicity, sensitivity, and versatility secure its role in cancer research, apoptosis assay, and drug screening workflows. Ongoing advances in workflow automation and combinatorial readouts (e.g., multiplexing with apoptosis markers) will further enhance the assay's impact. For validated, high-purity MTT, see the B7777 kit from APExBIO.

For further mechanistic or troubleshooting guidance, see: Reimagining Cell Viability and Metabolic Activity Measurement (which offers strategic context and mechanistic depth beyond the workflow emphasis here).